First of all, we have extraordinary scientific capacity in Quebec and Canada. We have everything we need to build a life sciences industry in Canada. Then again, the federal and provincial governments would need to recognize this industry as a real economic driver in Canada and Quebec.
Plus, the industry model has changed. We must recognize that it's less of a model with big buildings and big labs and more of a consolidated model with partnerships and investments.
In Quebec, you were able to attract Moderna to build a vaccine production company, and that's great. In Ontario, we have Sanofi producing vaccines. In British Columbia, we have companies like AbCellera that are able to make antibodies against COVID and other infectious diseases. We really have the capacity to do that, so we have to invest, work with industry, develop incentives and create a market that helps Canadian and multinational businesses market their products in Canada.
We shouldn't have to wait for Health Canada approval for a year and another two and a half years to be reimbursed for a drug. It can take up to three and a half years, whereas the United States and Germany reimburse for drugs immediately. Therefore, markets must be developed hand in hand with the innovation system in Canada.